2026-11-14 · 2026-11 / week-2

Suncrete’s guide reset does not bound a short after a 37% gap

Suncrete’s guide reset does not bound a short after a 37% gap

Summary: Suncrete cut its 2026 adjusted EBITDA midpoint 23% and its revenue midpoint 6.4%, while Q3 revenue and adjusted EBITDA grew sharply from Q2. RMIX closed Nov. 13 down 37.4% and recovered 5.1% after hours; at the latest reference of $5.34, a return to the $8.12 pre-result close is a 52.1% adverse stress and the $8.82 session high is 65.2% above the reference. The operating reset is real, but no model supports a 10% base decline with a 5% adverse bound. Reject / no trade.

Run field Value
Published November 14, 2026, 08:04 Singapore time
Research cutoff November 14, 2026, 08:04 Singapore time
Scope U.S.-listed short opportunities
Decision Reject / no trade screen
Reference RMIX, $5.34 after hours at 6:44 p.m. ET Nov. 13; regular close $5.08 at 4:00 p.m. ET. The latest after-hours mark was about 20 minutes old at cutoff.

Scope and Search Audit

The search covered three distinct mechanisms: a fresh operating-guidance reset against post-result price action; a noncash impairment and backlog/liquidity bridge; and fast growth with raised guidance despite a sharp price decline. SPY was the broad-market control.

RMIX appeared in earlier Desk articles only as a candidate comparison: the June screen discussed registered resale supply, while the August screen emphasized the dual-class denominator, acquisition stack, and resale registration. This article uses a different evidence boundary: Suncrete’s Nov. 13 Q3 results, revised FY26 guide, project timing, sequential operating trend, cash flow, and the resulting market response. The prior resale thesis is not reused. No RMIX, YSS, or HTFL article or signal was found on current main. The immediately preceding KLC and SPCE screens are not repeated.

Opportunity Ranking

Rank Candidate Direction Mispricing Evidence freshness Catalyst window Positioning 10/5 status Tradeability Main rejection risk
1 RMIX Short FY26 revenue and adjusted EBITDA guide midpoints fell 6.4% and 23.0%; the regular close fell 37.4%, while Q3 improved sequentially. Nov. 13 SEC release; Nov. 13 close and 6:44 p.m. ET after-hours mark. No dated issuer catalyst verified in the next 20 sessions; next regular session is a price-acceptance test only. MarketBeat reports 2.57M short shares, 4.50% of float and 4.29 days to cover at Oct. 30; stale before the result. Reject Event volume was high, but current spread, depth, borrow, locate, and exit capacity are unverified. A project-timing reset and strong sequential Q3 may limit follow-through; a return to the pre-result close and same-session high are 52.1% and 65.2% adverse moves from the after-hours reference.
2 YSS Short Q3 revenue fell 7%, gross profit fell 23%, and Adjusted EBITDA loss widened; a $749.7M goodwill impairment was noncash. Nov. 12 SEC results and 10-Q; Nov. 13 regular close. No dated near-term contract or earnings catalyst verified. Oct. 30 short interest was 11.93M shares and 7.2 days to cover; reported float is 8.69% at MarketBeat versus 13.69% at ChartExchange. Both figures predate the post-result session. Reject NYSE listing; current borrow and exit conditions unverified. $459M reported liquidity, $581M backlog, and an unchanged FY26 revenue-guide midpoint complicate a short.
3 HTFL Short Shares closed down 19.1% on Nov. 13, but Q3 revenue grew 57% and FY26 revenue guidance was raised. Nov. 12 SEC release; Nov. 13 close. No issuer event dated within the next 20 sessions was verified. Current short positioning not verified. Reject Nasdaq listing; spread, borrow, and exit data unverified. Strong growth and raised guidance make the operating short case weak; price weakness alone is not a thesis.
Control SPY Short Broad-market control; it does not isolate an issuer-specific short mechanism. Nov. 13 regular close. None for a standalone short. Index positioning does not establish an RMIX catalyst. No setup Liquid broad-market instrument. No differentiated short disagreement.

Selected research screen: RMIX ranks first for information value, not as the best executable short. It has the clearest fresh contradiction between a lower FY26 guide and a much stronger sequential quarter. No finalist passes the short hurdle.

Why this one now: The company reduced the adjusted EBITDA midpoint by almost one quarter after Q2 had maintained its outlook. But the post-result close fell more than the guide midpoints, and the after-hours quote rebounded. The move does not establish overreaction; it does make a fresh short’s adverse path difficult to bound.

What should surprise the reader: Q3 revenue rose 45% sequentially and adjusted EBITDA rose 66%, yet FY26 adjusted EBITDA guidance fell from an $80.5M midpoint to $62.0M. The tension is not “growth versus decline.” It is whether acquisition-led growth and project deferrals can produce the margins and cash that the new guide assumes.

Why This Is the Best Opportunity Right Now

RMIX offers the most current evidence on a short candidate’s earnings bridge. Its FY26 guide was maintained in August, then reset on Nov. 13. YSS also reported weaker Q3 margins, but its enormous goodwill impairment is noncash, while its backlog, liquidity, and FY26 revenue midpoint remain substantial. HTFL’s price fell sharply, but its company-reported growth and raised outlook do not support a clean short thesis. None has a verified 10/5 setup.

The ranking is about information value. RMIX is not called an attractive short, a best trade, or a valuation bargain. The latest price does not support a responsible estimate of fair value.

Why This Can Move More Than 5% Soon

RMIX’s Nov. 13 regular-session range was $5.02–$8.82. It closed at $5.08 versus $8.12 the prior day, then StockAnalysis reported $5.34 after hours at 6:44 p.m. ET. ChartExchange separately showed a $5.07 regular close and a $5.15 after-hours mark at 4:50 p.m. ET. The observations differ by provider and time; they are not averaged.

That range demonstrates volatility, not a forecast. The $5.02 low is only 6.0% below the $5.34 after-hours reference. The prior close is 52.1% above it. The next regular session on Nov. 16 is the first test of whether the market accepts the result-day price. It is not an issuer catalyst and cannot establish fair value.

10/5 Asymmetry Gate

A 10% decline from the $5.34 reference requires a price near $4.81. No cash-flow, debt, share-count, or valuation model supports $4.81 as the highest-probability outcome. The observed $5.02 session low is not a target and offers only 6.0% gross downside from the reference. A retrace to $8.12 is a 52.1% adverse rise; the $8.82 same-session high is a 65.2% stress. Neither is an upper bound.

The base case in the reference-only map is flat. The short therefore fails the 10% base-decline test, the 5% adverse bound, and the 2:1 gross reward-to-risk test before borrow, spread, slippage, fees, and carry. Reject before execution.

What Should Surprise the Reader

The headline revenue growth is partly acquired. Suncrete reported $140.96M Q3 revenue, up 163% year over year and 45% sequentially. Management described about 10% organic growth. The company also reported 32% more ready-mix yards than Q2 and an increase in Adjusted EBITDA from $13.5M to $22.4M. These are real operating improvements, although the organic-growth figure is management’s characterization.

The weaker part is margin and cash conversion. Q3 Adjusted EBITDA margin was about 15.9%, below roughly 25.6% a year earlier, even as it improved from about 13.9% in Q2. Nine-month operating cash flow was negative $8.2M; PP&E additions were $12.9M. Acquisition cash payments were $172.6M, plus $22.7M for a deferred acquisition liability. The company ended September with $49.0M cash after $259.1M of net financing cash inflow, including $167.1M from PIPE investors and $106.1M of debt borrowings before repayments and other uses. Adjusted EBITDA did not fund the acquisition program.

The Setup

Suncrete runs a ready-mix concrete production and delivery platform across Sunbelt construction markets. Q3 revenue was $140.96M versus $53.54M a year earlier. Gross profit was $39.54M. Operating income was $5.33M, net income was $78,000, and Adjusted EBITDA was $22.4M. The company reported that total yards produced and delivered rose 125% year over year and 32% sequentially. Acquisition contribution is material; the 163% revenue growth is not organic growth.

At August’s Q2 release, management maintained FY26 revenue guidance of $420M–$480M and Adjusted EBITDA of $68M–$93M. On Nov. 13 it cut those ranges to $408M–$434M and $60M–$64M. Revenue midpoint fell from $450M to $421M, or 6.4%. Adjusted EBITDA midpoint fell from $80.5M to $62.0M, or 23.0%. The revised guide assumes no significant change in Sunbelt economic conditions and excludes future acquisitions.

Management attributed the reset to some large projects shifting start dates into 2027 and higher interest rates pressuring residential construction. That is an issuer explanation, not proof that the work will begin later or be lost. The release did not identify project values, counterparties, cancellation rights, or revised start dates. Management expects further growth in 2027, but that forward-looking statement is not contracted revenue.

The Market Price

StockAnalysis/S&P Global reported a $5.08 regular close at 4:00 p.m. ET Nov. 13, down $3.04 or 37.44% from $8.12 on Nov. 12. Its page showed an $8.82 high, $5.02 low, and 2.849M shares traded. ChartExchange showed $5.07, a $5.02 low, and 2.846M shares; its 4:50 p.m. ET after-hours mark was $5.15. StockAnalysis later showed $5.34 at 6:44 p.m. ET, up 5.12% from its regular close. I use the later mark as a reference only.

The latest filed share count is dated Sept. 30: 49.339M Class A and 24.147M Class B shares. Multiplying their 73.486M combined count by $5.34 gives an indicative $392.4M equity value. It is not an enterprise value or a fully diluted valuation; later issuances and affiliated or other equity claims have not been reconciled. The provider’s $373.3M market-cap figure corresponds to the $5.08 regular close and is not mixed with the after-hours price.

A 10% decline from $5.34 would put the stock near $4.81. The available evidence does not show what operating result or claim value that price represents. No independent, timestamped consensus estimate was verified for this screen. A StockAnalysis analyst-target summary lacks a usable estimate-update date, so it is excluded from the price-implied case.

The Mispricing

Price: The regular-session close fell 37.4%, while the revenue and Adjusted EBITDA guide midpoints fell 6.4% and 23.0%. The percentages are not directly comparable: leverage, acquisition integration, margin, cash needs, and the two-class denominator all matter. The price move alone cannot show whether the market overreacted.

Reality: Q3 improved sharply from Q2, but Q3 Adjusted EBITDA margin remained well below the prior year. Nine-month operating cash flow was negative, and acquisitions required cash and debt financing. The new guide cut therefore meets real execution and financing risks.

Market belief: The price suggests investors assigned more weight to weaker FY26 earnings, project delays, residential exposure, and acquisition integration. This is an inference from the price and downgrade, not a measured consensus forecast. No independent current consensus was used.

Why the market may be wrong: The released evidence says projects moved into 2027, not that they were canceled. The company also reported sequential growth, improving Q3 margin, and about 10% organic revenue growth. If the timing shift is temporary and margins continue to recover, the current earnings reset may prove too severe.

Why the market may be right: The 23% EBITDA-midpoint cut is material; the new guidance is still issuer guidance, not cash already earned. Revenue growth was partly acquired, margins remain below last year, cash conversion is weak, and funded debt is large relative to cash. A better Q3 cannot by itself validate the 2027 project pipeline.

The Positioning

MarketBeat reports 2,573,392 shares short as of Oct. 30, equal to 4.50% of its public-float estimate and 4.29 days to cover. That settlement predates the Q3 release and Nov. 13 price gap. The percentage and days-to-cover are provider calculations, not live positioning. Current short interest, borrow cost, locate availability, recall terms, lender concentration, and post-event covering were not verified.

The reported short share count is not evidence of a crowded trade. With the price already down sharply, a short can still lose through re-rating, a gap, a halt, or poor exit liquidity.

The Catalyst

No issuer-announced event with a verified date was found inside the 20-session horizon through Dec. 14, 2026. The next regular-session price response on Nov. 16 is a market-acceptance observation, not a fundamental catalyst. Suncrete has not provided a dated next-results event or named the affected projects and start dates in the reviewed release.

The cheapest disconfirming sequence is: first, observe the Nov. 16–17 regular-session response; second, inspect any filing or call that identifies whether delayed projects are starting, delayed further, or canceled; third, compare Q4 margins and operating cash with the revised guide when results are reported. Until then, a lower quote alone does not falsify the counterparty case.

The Payoff

This is a 20-session reference-anchor sensitivity through Dec. 14, 2026, from the $5.34 after-hours mark. It uses the Nov. 13 regular-session low of $5.02, the $5.34 reference, and the $8.82 Nov. 13 session high. These are observed prices, not fair value, targets, or bounds.

The subjective 15% / 60% / 25% weights are analyst assumptions, not observed frequencies. The 15% top case revisits the session low if the guide reset dominates; the 60% base case is stabilization while project timing and Q4 cash conversion remain unresolved; the 25% bottom case retests the Nov. 13 session high if investors treat the guide cut as timing and shorts cover. None of these weights is supported by a historical event sample.

Price Target and Probability Map

Scenario Probability Target / level Short return from $5.34 Horizon Conditions Evidence quality
Top case 15% $5.02 +6.0% Through Dec. 14, 2026 Price revisits the Nov. 13 session low; the low is an observed anchor, not a target. Low
Base case 60% $5.34 0.0% Through Dec. 14, 2026 No new project, margin, or cash evidence; price stabilizes near the after-hours reference. Low
Bottom case 25% $8.82 -65.2% Through Dec. 14, 2026 Price retests the Nov. 13 session high after investors treat the guide cut as timing. The high is not a ceiling. Low
Invalidation n/a No fixed price stop Rebuild if revised guidance is restored or project timing and margins improve enough to change the operating bridge. Any time Verify filings, project starts, cash flow, debt, and share count. Medium
Payoff check Result
Probability-weighted expected price $6.16
Probability-weighted gross short return -15.4% before borrow, spread, slippage, fees, and carry
Current market level and timestamp $5.34, Nov. 13, 2026, 6:44 p.m. ET; after-hours reference
Primary instrument RMIX common stock, screening only
10/5 favorable base move 0.0%; the base case is flat
10/5 credible adverse move +52.1% to the pre-result close and +65.2% to the same-session high; further upside is possible
10/5 measurement basis Reference-only; no verified executable entry
10/5 status Reject
Gross base reward/adverse ratio 0.0:1; the 6.0% top-case marker versus the 65.2% high stress is about 0.09:1
Confidence Low; observed price anchors, subjective weights, stale positioning, and no current execution data

The Kill Shot

The strongest counterparty case is that the selloff overstates a project-timing issue. Q3 revenue, total yards, and Adjusted EBITDA all rose sequentially, while the margin improved from Q2. Management said large projects shifted to 2027 rather than saying they were canceled. If those starts occur and acquisition integration improves margins, the new guide may be conservative. The 5.12% after-hours recovery from the regular close is too short a sample to prove that outcome, but it shows the gap can rebound.

The fragile short assumption is that the shifted projects fail to arrive and the lower Adjusted EBITDA guide will be cut again. The company’s cash-flow and debt bridge raises that risk, but the reviewed documents do not identify project-level commitments or a near-term trigger. The risk is not bounded at 5%, and the economic case does not pass 10/5.

What Could Go Wrong

The short can lose if deferred projects start, commercial or infrastructure demand offsets residential weakness, acquired operations improve margins, or the market revalues the platform on FY27 growth. The current AH quote is reference-only; the Nov. 13 regular-session low is not a floor and the prior close is not a ceiling. A gap, halt, borrow recall, high fees, spread widening, or thin exit book can increase losses even if the operating thesis is directionally right.

What Would Prove This Wrong

Retire the short concern if later filings show delayed projects starting on schedule, sustained organic growth, recovering margins, and cash conversion consistent with or above the revised guide. A recovery through $8.12 would invalidate the result-gap framing, though it would not prove fair value. If Q4 results miss the revised guide or project timing slips again, rebuild the analysis with the new quarter, cash, debt, share count, and a fresh regular-session quote; do not treat another decline as an automatic trade trigger.

Risk Audit

Risk Evidence Effect on decision
Guidance FY26 Adjusted EBITDA midpoint fell 23.0%; management cites project deferrals and residential rate pressure. Supports the bear case, but no project values or cancellations were disclosed.
Sequential recovery Q3 revenue rose 45% and Adjusted EBITDA rose 66% from Q2; margin rose to about 15.9% from 13.9%. Strongest squeeze countercase; Q3 margin remained below the prior-year 25.6%.
Cash conversion Nine-month operating cash flow was -$8.2M and capex was $12.9M. Adj. EBITDA is not free cash flow.
Acquisition funding $172.6M acquisition cash and $22.7M deferred consideration were paid; financing cash inflow was $259.1M. Growth and liquidity depend on financing and integration, not only recurring cash generation.
Debt and claims Sep. 30 funded debt totaled about $259.2M versus $49.0M cash; Class A/B and other claims complicate equity value. Raises downside risk but does not produce a defensible price target.
Positioning 4.50% provider-estimated float short at Oct. 30; stale before the event. No evidence of a squeeze-crowded or freshly positioned trade.
Execution No fresh regular-session post-event quote, spread, depth, locate, borrow cost, recall terms, or exit capacity at the next session. Keep entry null and execution disabled.

Best Trade Strategy

No trade. RMIX common stock is the only expression considered; there is no verified executable entry and no trade-qualified price target. Reconsider only after regular-session price acceptance, a sourced project and cash-flow update, and a model that supports at least a 10% base decline, no more than 5% credible adverse rise, at least 2:1 gross reward-to-risk, and positive value after realistic costs. Locate, borrow fee and recall terms, spread, depth, volume quality, and exit liquidity must also be verified. Do not use options, leverage, margin, market orders, or price-floor logic.

Sources

Research Quality Scorecard

Criterion Score Evidence-based reason
Market disagreement 4/5 The new guide cut conflicts with sequential Q3 improvement, but no reliable price-implied valuation was derived.
Evidence base 4/5 Fresh SEC results and cash-flow tables, prior guide, and multiple quote sources; execution and updated positioning remain missing.
Positioning and flows 2/5 Oct. 30 short interest is stale and provider-estimated; current borrow and covering are unknown.
Catalyst path 2/5 Next session tests price acceptance, but no dated issuer catalyst was verified inside the horizon.
Payoff architecture 2/5 The flat base, 6.0% top marker, and 65.2% adverse stress fail the short hurdle.
Invalidation discipline 4/5 Project timing, revised guidance, margin, and cash flow are monitorable.
Differentiated insight 4/5 Separates a genuine FY26 operating reset from a strong acquired and sequential Q3, and from the older resale-share discussion.
Client value 5/5 Explains why a real guide cut after a large gap does not establish another bounded short.
Total 27/40 Short note / no-trade screen. The failed 10/5 economics require Reject.

Bottom Line

Suncrete cut its FY26 adjusted EBITDA midpoint by 23%, but Q3 improved sequentially and management described project starts moving into 2027 rather than cancellations. At the $5.34 after-hours reference, the base short return is flat, a retest of the session low offers 6.0%, and a return to the prior close or same-session high is a 52.1% or 65.2% adverse move. Reject / no trade.

AI Illustration Prompt

Create a restrained institutional research illustration: a Sunbelt concrete mixer truck paused beside a commercial job site with a small 2027 project calendar in the background. Overlay a compact ledger reading “Q3 Revenue $141M”, “FY26 Adj. EBITDA Guide $60M–$64M”, “Cash $49M”, and “Funded Debt $259M”. Add a price strip reading “RMIX $5.34 AH; Nov. 13 close $5.08; reference only”. Use warm concrete gray, deep navy, and one muted amber accent. Avoid company logos and construction-worker portraits. Add a subtle readable “The Mispricing Desk” watermark.